MACFARLANE M DAVID 4
4 · TITAN PHARMACEUTICALS INC · Filed Sep 25, 2018
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
MACFARLANE M DAVID
Director
Transactions
- Purchase
Common Stock
2018-09-21$0.25/sh+80,000$20,000→ 102,275 total - Award
Warrants
2018-09-21+80,000→ 80,000 totalExercise: $0.25From: 2018-09-25Exp: 2023-09-25→ common stock (80,000 underlying)